Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00163384
Status:
COMPLETED
Last Update Posted:
2016-11-30
First Post:
2005-09-12
Brief Title:
Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma 18 to 75 y BY9010M1-136
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Comparative Study of Inhaled Ciclesonide 160 mcgDay vs Budesonide 400 mcgDay in Patients With Asthma
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial will compare the effectiveness of one dose of ciclesonide against one dose of budesonide in patients with asthma
The aim of the present trial is to compare the efficacy of ciclesonide versus budesonide on pulmonary function symptoms and use of rescue medication in patients with asthma The onset of action and the safety and tolerability of ciclesonide in comparison to budesonide will also be investigated
The aim of the present trial is to compare the efficacy of ciclesonide versus budesonide on pulmonary function symptoms and use of rescue medication in patients with asthma The onset of action and the safety and tolerability of ciclesonide in comparison to budesonide will also be investigated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None